CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr. CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr.  CARMINA MONTOLIU, UNIVERSIDAD DE VALENCIA/INCLIVA,  Spain.

Carmina Montoliu Felix, a Valencia-born scientist and educator, is a distinguished Catedrática de Universidad at the Universidad de Valencia, specializing in Cellular Biology and Pathology. With a strong foundation in biomedical sciences and a dual role in both academia and clinical research through INCLIVA, she has become a key figure in translational medicine in Spain. Her work focuses on uncovering cellular mechanisms of disease, supported by national recognition such as her Group A classification by ISCIII. With extensive contributions indexed on platforms like ORCID and Scopus, she has gained international visibility and continues to influence the fields of pathology and biomedicine.

Profile

Orcid

 

🎓 Early Academic Pursuits

Carmina Montoliu Felix was born in Valencia, where she also pursued her academic career rooted in the life sciences. Her early interest in biology and medical sciences led her through a rigorous academic pathway that would eventually shape her into a leading figure in cellular pathology. With a profound dedication to understanding human disease at the cellular level, she cultivated a strong foundation in biology, which became the cornerstone of her future specialization in Cellular Biology and Pathology. These formative years instilled in her a passion for translational research, which continues to drive her work.

🏛️ Professional Endeavors

Currently serving as a Catedrática de Universidad at the Facultad de Medicina y Odontología of the Universidad de Valencia, Carmina Montoliu Felix holds a prestigious position within the Departamento de Patología, specifically in the Unidad de Biología. She achieved this distinguished academic rank on November 3, 2023, under BOE nº 274, a recognition of her academic excellence and contributions to higher education. Alongside her academic post, she is also an investigadora adscrita at the Fundación INCLIVA, playing a dual role in both teaching and active biomedical research. Her employment reflects the seamless integration between university instruction and clinical research aimed at improving patient outcomes.

🧬 Contributions and Research Focus

Carmina Montoliu Felix has been a pivotal contributor to the field of Cellular Biology, with specific expertise in Pathology (Área 661). Since February 29, 2012, she has been classified as a Group A Researcher within the Instituto de Salud Carlos III (ISCIII) framework. Her research activities are aligned with the Programa de Estabilización de Investigadores and the Sistema Nacional de Salud (I3SNS), focusing on intensifying biomedical research and fostering translational discoveries. Her scientific work is characterized by its interdisciplinary nature and commitment to uncovering the molecular basis of diseases, contributing significantly to both national and international health research landscapes.

🏅 Accolades and Recognition

Dr. Montoliu Felix’s academic excellence has been affirmed through numerous accolades, including the Group A classification by the Comisión Técnica de Evaluación de Recursos Humanos del ISCIII, one of the highest distinctions for biomedical researchers in Spain. Her appointment as a full professor is a testament to her leadership in medical education and scientific research. She is widely recognized among her peers for her scholarly impact, rigor, and commitment to nurturing future scientists and medical professionals.

🌍 Impact and Influence

Her work not only resonates within academic circles but also extends into clinical research through her active role at INCLIVA. By integrating research and practice, Carmina Montoliu Felix exemplifies how scientific inquiry can lead to tangible health benefits. Her influence spans collaborations with national healthcare systems and academic institutions, reinforcing her role as a key figure in the biomedical field. Through platforms such as ORCID and Scopus (ORCID ID: 0000-0002-4740-4788; Scopus ID: 6701923138), her contributions are accessible globally, further amplifying her scientific impact.

🔬 Legacy and Future Contributions

With a career marked by consistent advancement and dedication to discovery, Carmina Montoliu Felix is poised to continue shaping the future of cellular pathology and biomedical research in Spain and beyond. Her dual engagement in academia and clinical research ensures that her legacy will include both scientific breakthroughs and a generation of inspired students and researchers. Looking ahead, she is expected to further expand the integration of molecular biology into clinical diagnostics, ultimately improving patient care through science.

📚 A Life Committed to Science and Society

Beyond her technical expertise and professional roles, Carmina Montoliu Felix embodies the ideals of a scholar deeply committed to the betterment of society through science. Her residence and professional base in Valencia, her continuous academic contributions, and her service within public institutions paint the portrait of a researcher who bridges the lab and the community. Through her enduring efforts, she not only advances knowledge but also enhances the collective understanding of human health and disease.

Publication

  • Title: Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
    Authors: Lyudmila Tikhonova; Eugene Maevsky; Carmina Montoliu; Elena Kosenko
    Year: 2025

 

  • Title: Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence
    Authors: Gubidat Alilova; Lyudmila Tikhonova; Carmina Montoliu; Elena Kosenko
    Year: 2024

 

  • Title: Automatic Video-Oculography System for Detection of Minimal Hepatic Encephalopathy Using Machine Learning Tools
    Authors: Alberto Calvo Córdoba; Cecilia Elisabet García Cena; Carmina Montoliu
    Year: 2023

 

  • Title: Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
    Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Amparo Urios; MP Ballester; Teresa San-Miguel; Javier Megías Vericat; Elena Kosenko; Tosca J; Maria-Pilar Rios et al.
    Year: 2023

 

  • Title: Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease
    Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Carla Giménez-Garzó; Amparo Urios; MP Ballester; Lucia Durbán; Maria-Pilar Rios; Javier Megías Vericat; Teresa San-Miguel et al.
    Year: 2023

 

  • Title: Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease
    Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
    Year: 2023

 

  • Title: Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy
    Authors: Juan José Gallego; Alessandra Fiorillo; Franc Casanova-Ferrer; Amparo Urios; MP Ballester; Lucia Durbán; Javier Megías; Teresa Rubio; Andrea Cabrera-Pastor; Desamparados Escudero-García et al.
    Year: 2022

 

  • Title: Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
    Authors: Teresa San-Miguel; Javier Megías; Daniel Monleon; Lara Navarro Cerveró; Lisandra Muñoz; Carmina Montoliu; Marina Meri; Pedro Roldán; Miguel Cerdá-Nicolás; Concha López-Ginés
    Year: 2022

 

  • Title: Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?
    Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
    Year: 2022

 

  • Title: A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease
    Authors: Carla Giménez-Garzó; Alessandra Fiorillo; MP Ballester; Juan José Gallego Roig; Franc Casanova-Ferrer; Amparo Urios; Salvador Benlloch; Marti-Aguado D; Teresa San-Miguel; Tosca J et al.
    Year: 2021

 

Conclusion

Carmina Montoliu Felix’s career reflects a rare blend of scientific rigor, academic leadership, and social impact. Her journey from student to full professor showcases her dedication to advancing both knowledge and healthcare. As she continues to lead research at the intersection of cellular biology and clinical application, her legacy will not only be measured in published studies and prestigious titles, but also in the real-world health outcomes and inspired minds her work cultivates. Her future contributions promise to deepen our understanding of disease and strengthen the bridge between science and society.

 

Wei Li | Cognitive Rehabilitation | Best Researcher Award

Prof. Wei Li | Cognitive Rehabilitation | Best Researcher Award

Prof. Wei Li, Affiliated Hospital of Binzhou Medical University, China.

Professor Wei Li is a distinguished leader in the field of rehabilitation medicine, with a strong foundation in biomedical engineering and over 15 years of clinical and academic experience. Trained at Capital Medical University and PLA General Hospital, he now serves as a Professor, Chief Physician, and Director at the Affiliated Hospital of Binzhou Medical University. His contributions span across clinical rehabilitation, biomechanics, and innovative rehabilitation engineering. Through his leadership in national and provincial research projects, mentorship of young scholars, and roles in major events like the Beijing Winter Olympics, Professor Li has solidified his reputation as a pioneer and innovator in the integration of technology and patient care.

Profile

Scopus

 

🎓 Early Academic Pursuits

Professor Wei Li embarked on his academic journey with a deep passion for medical science and engineering, earning his Ph.D. in Biomedical Engineering from the esteemed Capital Medical University. His early years were marked by rigorous academic training and a strong inclination towards the integration of technology in medicine. His postdoctoral research at the PLA General Hospital further shaped his expertise, especially in the realms of biomechanics and clinical rehabilitation. This foundational phase instilled in him a scientific rigor and a vision to bridge the gap between biomedical engineering and practical healthcare solutions.

🩺 Professional Endeavors

With over 15 years of hands-on clinical and academic experience, Professor Wei Li currently serves as a Professor, Chief Physician, and Director of both the Department of Rehabilitation Medicine and the Department of Science & Technology at the Affiliated Hospital of Binzhou Medical University. His dual leadership roles reflect not only his clinical excellence but also his strategic insight in advancing research and development within the hospital. He plays a vital role in shaping the institution’s medical innovation ecosystem and fostering interdisciplinary collaborations that drive translational research into rehabilitation technologies.

🧠 Contributions and Research Focus

Professor Li’s research centers around clinical rehabilitation, biomechanics, and rehabilitation engineering, where he explores advanced therapeutic interventions to enhance patient recovery outcomes. His work integrates cutting-edge biomedical engineering with evidence-based clinical practices, making notable strides in the development of customized rehabilitation protocols and assistive technologies. With six major research projects under his leadership—four as Principal Investigator—he has made significant contributions to projects funded by prestigious bodies like the National Key R&D Program of China, the Shandong Provincial Natural Science Foundation, and the Beijing Natural Science Foundation.

🏆 Accolades and Recognition

Throughout his illustrious career, Professor Wei Li has received numerous honors that reflect his outstanding service and innovation in rehabilitation medicine. He has been named a National Clinical Specialty Leader, an acknowledgment reserved for top-tier medical professionals in China. Notably, he was selected as a Medical Expert for the Beijing Winter Olympics, showcasing his role in elite sports medicine and rehabilitation support. His research achievements have garnered several provincial scientific awards, underlining his contributions to the field’s academic and practical advancements.

🌐 Impact and Influence

Professor Li’s influence extends beyond the hospital and research lab. He is a mentor to emerging scientists and postdoctoral researchers, guiding the next generation of rehabilitation engineers and clinical researchers. His mentorship has created a ripple effect in nurturing talent and promoting interdisciplinary research. He frequently participates in national academic forums, contributing to policy discussions and the development of standardized practices in rehabilitation medicine across China.

Publication

  • Title: Metabolism-Related Adipokines and Metabolic Diseases: Their Role in Osteoarthritis
    Authors: Zhang, Qian; Zhao, Yixuan; Li, Longfei; Li, Chen; Li, Wei
    Year: Not specified (likely 2024 or 2025 based on context)

 

  • Title: Surface Electromyography and Gait Features in Patients after Anterior Cruciate Ligament Reconstruction
    Authors: Wu, Xipeng; Zhang, Hao; Cui, Hongxing; Cao, Zhijie; Li, Wei
    Year: 2025

 

  • Title: Dorsal raphe dopaminergic neurons target CaMKII+ neurons in dorsal bed nucleus of the stria terminalis for mediating depression-related behaviors
    Authors: Wang, Wentao; Wang, Dan; Zhao, Di; Li, Wei; Li, Chen
    Year: 2024

 

 

🏁 Conclusion

Professor Wei Li’s career is a testament to the power of interdisciplinary excellence, where science, medicine, and technology converge to transform patient rehabilitation. His impactful research, visionary leadership, and unwavering dedication to both education and innovation continue to inspire the medical community. As he moves forward, his efforts are not only shaping the future of rehabilitation medicine in China but also setting a global standard for integrated, patient-centric care through biomedical innovation.